Association between bariatric surgery and outcomes in chronic myeloid leukemia
Authors:
- Aram BidikianABAram Bidikian
- Elias J. JabbourEJElias J. Jabbour
- Nicholas J. ShortNicholas J. Short
- Jing NingJNJing Ning
- Lianchun XiaoLXLianchun Xiao
- Naveen PemmarajuNPNaveen Pemmaraju
- Courtney D. DiNardoCDCourtney D. DiNardo
- Tapan M. KadiaTKTapan M. Kadia
- Kayleigh R. MarxKMKayleigh R. Marx
- Guillermo Garcia‐ManeroGGGuillermo Garcia‐Manero
Abstract
Background: Bariatric surgery is the most effective weight loss intervention. However, it can also decrease the bioavailability of oral medications. Tyrosine kinase inhibitors, the mainstay treatment for chronic myeloid leukemia (CML), are the most successful example of an oral targeted therapy. The impact of bariatric surgery on CML outcomes is unknown.Methods: In a retrospective analysis, we screened 652 patients with CML and identified 22 with prior bariatric surgery, and compared their outcomes to a matched cohort of 44 patients with no prior bariatric surgery.Results: The rate of early molecular response (3‐month BCR::ABL1 < 10% International Scale) was lower in the bariatric surgery group compared with the control group (68% vs. 91%; p = .05), with longer median times to achieve complete cytogenetic (6 vs. 3 months; p = .001) or major molecular responses (12 vs. 6 months; p = .001). Bariatric surgery was associated with inferior event‐free survival (5‐year, 60% vs. 77%; p = .004) and failure‐free survival (5‐year, 32% vs. 63%; p < .0001). In a multivariate analysis, bariatric surgery was the only independent predictor for the risk of treatment failure (hazard ratio, 9.40; 95% CI, 2.71–32.55; p = .0004) or event‐free survival (hazard ratio, 4.24; 95% CI, 1.67–12.23; p = .008).Conclusions: Bariatric surgery is associated with suboptimal responses that require adapted treatment strategies.Keywords
This publication has 16 references indexed in Scilit:
- Mechanisms underlying weight loss after bariatric surgeryNature Reviews Gastroenterology & Hepatology, 2013
- Alcohol consumption and alcohol problems after bariatric surgery in the swedish obese subjects studyObesity, 2013
- Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgeryJournal of Internal Medicine, 2013
- The effects of gastric bypass surgery on drug absorption and pharmacokineticsExpert Opinion on Drug Metabolism & Toxicology, 2012
- Reduction of imatinib absorption after gastric bypass surgeryLeukemia & Lymphoma, 2010
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNetJournal of Clinical Oncology, 2009
- Long-Term Mortality after Gastric Bypass SurgeryNew England Journal of Medicine, 2007
- Effects of Bariatric Surgery on Mortality in Swedish Obese SubjectsNew England Journal of Medicine, 2007
- Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2005
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003